Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) FCF Margin (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed FCF Margin for 8 consecutive years, with 612.3% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, FCF Margin rose 89245.0% year-over-year to 612.3%, compared with a TTM value of 8078.46% through Sep 2025, down 473745.0%, and an annual FY2024 reading of 20744.88%, down 1954569.0% over the prior year.
  • FCF Margin was 612.3% for Q3 2025 at Bicycle Therapeutics, up from 2509.73% in the prior quarter.
  • Across five years, FCF Margin topped out at 512.67% in Q3 2021 and bottomed at 2509.73% in Q2 2025.
  • Average FCF Margin over 5 years is 601.36%, with a median of 612.3% recorded in 2025.
  • The sharpest move saw FCF Margin tumbled -263865bps in 2021, then soared 114282bps in 2022.
  • Year by year, FCF Margin stood at 1520.88% in 2021, then soared by 75bps to 378.06% in 2022, then soared by 177bps to 289.62% in 2023, then crashed by -84bps to 45.13% in 2024, then tumbled by -1457bps to 612.3% in 2025.
  • Business Quant data shows FCF Margin for BCYC at 612.3% in Q3 2025, 2509.73% in Q2 2025, and 871.75% in Q1 2025.